Emerging Technologies
The high cost of drugs is the price we pay for innovation
The process of discovering and developing new drugs is highly challenging and laden with risks, and this costs.
Ross Breckenridge was a physician and clinical scientist for 20 years in the UK National Health Service, and is now the chief executive of Silver Creek Pharmaceuticals in San Francisco, California.